Abstract
Oral squamous cell carcinoma (OSCC) is a subset of head and neck squamous cell carcinoma (HNSCC), the 7th most common cancer worldwide, and accounts for more than 90% of oral malignancies. Early detection of OSCC is essential for effective treatment and reducing the mortality rate. However, the gold standard method of microscopy-based histopathological investigation is often challenging, time-consuming and relies on human expertise. Automated analysis of oral biopsy images can aid the histopathologists in performing a rapid and arguably more accurate diagnosis of OSCC. In this study, we present deep learning (DL) based automated classification of 290 normal and 934 cancerous oral histopathological images published by Tabassum et al (Data in Brief, 2020). We utilized transfer learning approach by adapting three pre-trained DL models to OSCC detection. VGG16, InceptionV3, and Resnet50 were fine-tuned individually and then used in concatenation as feature extractors. The concatenated model outperformed the individual models and achieved 96.66% accuracy (95.16% precision, 98.33% recall, and 95.00% specificity) compared to 89.16% (VGG16), 94.16% (InceptionV3) and 90.83% (ResNet50). These results demonstrate that the concatenated model can effectively replace the use of a single DL architecture.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was sponsored by the NCBC Precision Medicine Lab funded by the Higher Education Commission, Pakistan.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
RMI Ethiics Committee, Rehman Medical Institute, Peshawar, Pakistan
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used a publicly available dataset, published by Tabassum et al, Data in Brief, 2020.
